SE0100901D0 - New composition - Google Patents

New composition

Info

Publication number
SE0100901D0
SE0100901D0 SE0100901A SE0100901A SE0100901D0 SE 0100901 D0 SE0100901 D0 SE 0100901D0 SE 0100901 A SE0100901 A SE 0100901A SE 0100901 A SE0100901 A SE 0100901A SE 0100901 D0 SE0100901 D0 SE 0100901D0
Authority
SE
Sweden
Prior art keywords
new composition
composition
lipoglobules
inflammation
pain
Prior art date
Application number
SE0100901A
Other languages
English (en)
Inventor
Britta Siekmann
Barbro Thoring
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100901A priority Critical patent/SE0100901D0/sv
Publication of SE0100901D0 publication Critical patent/SE0100901D0/sv
Priority to KR10-2003-7011860A priority patent/KR20030082971A/ko
Priority to US10/471,378 priority patent/US20040096494A1/en
Priority to CA002435825A priority patent/CA2435825A1/en
Priority to MXPA03007093A priority patent/MXPA03007093A/es
Priority to CNA028065271A priority patent/CN1496253A/zh
Priority to IL15681802A priority patent/IL156818A0/xx
Priority to JP2002572990A priority patent/JP2004523577A/ja
Priority to EP02704035A priority patent/EP1370239A1/en
Priority to PCT/SE2002/000476 priority patent/WO2002074282A1/en
Priority to BR0207760-4A priority patent/BR0207760A/pt
Priority to ZA200306282A priority patent/ZA200306282B/en
Priority to NO20034026A priority patent/NO20034026L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0100901A 2001-03-15 2001-03-15 New composition SE0100901D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition
BR0207760-4A BR0207760A (pt) 2001-03-15 2002-03-13 Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
MXPA03007093A MXPA03007093A (es) 2001-03-15 2002-03-13 Nueva composicion.
US10/471,378 US20040096494A1 (en) 2001-03-15 2002-03-13 Composition
CA002435825A CA2435825A1 (en) 2001-03-15 2002-03-13 New composition
KR10-2003-7011860A KR20030082971A (ko) 2001-03-15 2002-03-13 신규 조성물
CNA028065271A CN1496253A (zh) 2001-03-15 2002-03-13 新组合物
IL15681802A IL156818A0 (en) 2001-03-15 2002-03-13 New composition
JP2002572990A JP2004523577A (ja) 2001-03-15 2002-03-13 新規組成物
EP02704035A EP1370239A1 (en) 2001-03-15 2002-03-13 New composition
PCT/SE2002/000476 WO2002074282A1 (en) 2001-03-15 2002-03-13 New composition
ZA200306282A ZA200306282B (en) 2001-03-15 2003-08-13 New composition.
NO20034026A NO20034026L (no) 2001-03-15 2003-09-11 Nytt preparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition

Publications (1)

Publication Number Publication Date
SE0100901D0 true SE0100901D0 (sv) 2001-03-15

Family

ID=20283373

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition

Country Status (13)

Country Link
US (1) US20040096494A1 (sv)
EP (1) EP1370239A1 (sv)
JP (1) JP2004523577A (sv)
KR (1) KR20030082971A (sv)
CN (1) CN1496253A (sv)
BR (1) BR0207760A (sv)
CA (1) CA2435825A1 (sv)
IL (1) IL156818A0 (sv)
MX (1) MXPA03007093A (sv)
NO (1) NO20034026L (sv)
SE (1) SE0100901D0 (sv)
WO (1) WO2002074282A1 (sv)
ZA (1) ZA200306282B (sv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
EP1429749A2 (en) 2001-09-26 2004-06-23 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
GB0207529D0 (en) 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
WO2004004648A2 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
MXPA06013437A (es) * 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
EP1886667A1 (en) * 2006-08-08 2008-02-13 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Microemulsified drug formulation
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
WO2012125214A1 (en) * 2011-03-17 2012-09-20 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9724419B2 (en) * 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271937A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9849160B2 (en) * 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271731A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295637B2 (en) * 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US20140271938A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
CA3053865A1 (en) * 2017-02-21 2018-08-30 Dsm Ip Assets B.V. Use of a feed composition for reducing methane emission in rumi-nants, and/or to improve ruminant performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
SE9704833D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
KR20030082971A (ko) 2003-10-23
CA2435825A1 (en) 2002-09-26
IL156818A0 (en) 2004-02-08
EP1370239A1 (en) 2003-12-17
CN1496253A (zh) 2004-05-12
MXPA03007093A (es) 2003-11-18
BR0207760A (pt) 2004-06-01
US20040096494A1 (en) 2004-05-20
NO20034026L (no) 2003-11-11
ZA200306282B (en) 2004-11-23
WO2002074282A1 (en) 2002-09-26
NO20034026D0 (no) 2003-09-11
JP2004523577A (ja) 2004-08-05

Similar Documents

Publication Publication Date Title
SE0100901D0 (sv) New composition
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR0215405A (pt) Composições e processos de uso de collajolie
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
IT1318524B1 (it) Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
SE0001916D0 (sv) Novel formulation
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
SE0000303D0 (sv) Novel compounds
DE60003074D1 (de) Fusidinsäure-derivate
WO2002070537A3 (en) Fusidic acid derivatives
DE50212538D1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzoäcüfluoren-6-carbonsäurederivate als nmda-antagonisten
KR970019821A (ko) 송진을 함유한 치약 제조 방법
EA200300789A1 (ru) Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи